New Zealand markets closed

Pyxis Oncology, Inc. (PYXS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.6500-0.1100 (-2.93%)
At close: 04:00PM EDT
3.7000 +0.05 (+1.37%)
After hours: 07:51PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
16,146
0
0
0
0
-
Operating expenses
Research development
50,714
49,586
86,129
51,054
9,048
-
Selling general and administrative
31,804
32,610
37,352
18,663
3,846
-
Total operating expenses
82,518
82,196
123,481
69,717
12,894
-
Operating income or loss
-66,847
-82,196
-123,481
-69,717
-12,894
-
Total other income/expenses net
2,537
1,776
-
-6,281
-
-
Income before tax
-57,803
-73,790
-120,717
-75,975
-12,828
-
Income from continuing operations
-57,803
-73,790
-120,717
-75,975
-12,828
-
Net income
-57,803
-73,790
-120,717
-75,975
-12,828
-
Net income available to common shareholders
-57,803
-73,790
-120,717
-75,975
-12,828
-
Basic EPS
-2.56
-
-3.65
-8.95
-0.58
-0.13
Diluted EPS
-2.56
-
-3.65
-8.95
-0.58
-0.13
Basic average shares
37,485
-
33,033
8,493
22,127
21,975
Diluted average shares
37,485
-
33,033
8,493
22,127
21,975